Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$3.21 USD
0.00 (-0.10%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.21 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth A Momentum D VGM
Price, Consensus and EPS Surprise
AWH 3.21 0.00(-0.10%)
Will AWH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AWH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AWH
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
AWH: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Aspira (AWH) Rating Upgrade to Buy
ReWalk Robotics (RWLK) Reports Q2 Loss, Tops Revenue Estimates
Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates
Other News for AWH
Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch
Aspira Women's Health launches updated OvaWatch
Aspira Women's Health resumed with a Buy at Alliance Global Partners
Aspira Women’s Health Executive Minh Merchant Resigns
Aspira Women's Health files for $100M mixed securities shelf